STEAP1 Knockdown Decreases the Sensitivity of Prostate Cancer Cells to Paclitaxel, Docetaxel and Cabazitaxel
Sandra M. Rocha(University of Beira Interior), Cláudio J. Maia(University of Beira Interior)
Cited by 7
Related Papers
STEAP1 regulation and its influence modulating the response of LNCaP prostate cancer cells to bicalutamide, enzalutamide and apalutamide
|Molecular Medicine Reports|2023|5